posterior leukoencephalopathy syndrome

posterior leukoencephalopathy syndrome

a reversible clinicoradiologic syndrome characterized by confusion, headaches, seizures, cortical blindness and other visual abnormalities, emesis, and motor signs, associated with MRI or CT evidence of bilateral white matter edema involving the parietooccipital cerebral regions.

pos·te·ri·or leu·ko·en·ceph·a·lop·a·thy syn·drome

(pos-tēr'ē-ŏr lū'kō-en-sef'ă-lop'ă-thē sin'drōm)
A reversible clinicoradiologic syndrome characterized by confusion, headaches, seizures, cortical blindness, and other visual abnormalities, emesis, and motor signs; associated with MRI or CT evidence of bilateral white matter edema involving the parietooccipital cerebral regions.
References in periodicals archive ?
Posterior reversible encephalopathy syndrome (PRES) is known as reversible posterior leukoencephalopathy syndrome, primarily portrayed in 1996.
Clinical spectrum of reversible posterior leukoencephalopathy syndrome.
Posterior reversible encephalopathy syndrome (PRES) or reversible posterior leukoencephalopathy syndrome was first described by Hinchey, in 1996, as a reversible syndrome manifested with an acute headache, consciousness impairment, seizures, and visual deficits, associated with white matter changes predominately affecting the posterior parietal and occipital lobes of the brain but also involving the brainstem, cerebellum, and other cerebral areas [1-3].
Herein, we describe the first reported Japanese case of reversible posterior leukoencephalopathy syndrome (RPLS) that developed on receiving sunitinib therapy for metastatic RCC.
DeBaun, "Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease," Blood, vol.
Reversible posterior leukoencephalopathy syndrome after blood transfusion in a pediatric patient with sickle cell disease.
Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer.
Hinchey et al (3) first described reversible posterior leukoencephalopathy syndrome (which later became known as PRES) in 1996.
Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome.

Medical browser ?
Full browser ?